Abstract
Substituted indole scaffolds are often utilized in medicinal chemistry as they regularly possess significant pharmacological activity. Therefore the development of simple, inexpensive and efficient methods for alkylating the indole heterocycle continues to be an active research area. Reported are reactions of trichloroacetimidate electrophiles and indoles to address the challenges of accessing alkyl decorated indole structures. These alkylations perform best when either the indole or the imidate is functionalized with electron withdrawing groups to avoid polyalkylation.
Keywords: Indole, Alkylation, Friedel-Crafts, Lewis Acid
Graphical Abstract

Indole-based structures have found uses in many enterprises supported by organic chemistry,[1] having an especially large impact on medicinal chemistry.[2] Indoles substituted with benzyl groups at the C3 position are an especially common pharmacophore, being found in many pharmacologically active systems. These systems include anti-tuberculosis agents like 1,[3] anti-hyperglycemic compounds like 2,[4] along with antitumor compounds like the autotaxin inhibitor 3[5] and the topoisomerase inhibitor 4[6] (Figure 1). Additionally, medicinal chemistry studies in our laboratory have led to the investigation of structures like 5 as potential SHIP phosphatase inhibitors.[7] Clinical success with these structures has also been documented, as demonstrated by the asthma treatment zafirlukast 6.[8] Owing to their ubiquitous nature, a number of synthetic approaches to the indole ring system have been developed.[9] Attention has now turned to the rapid derivatization and diversification of this heterocycle.[10] Taking advantage of the nucleophilic nature of indole, great strides have been made in the addition of indoles to electron poor alkenes,[10b,11] addition to carbonyls/imines[10b, 10c] and new indole arylation/vinylation reactions.[12] In contrast, functionalization of indoles with sp3-hybridized electrophiles has received significantly less attention.[10a,13] The direct introduction of alkyl groups to simple indole systems is often problematic, as selectivity problems (C3 vs. N-alkylation, mono vs. polyalkylation) are common when alkyl halides are employed with rare exceptions.[14]
Figure 1.
Biologically active 3-benzylindoles.
Problems with alkyl halides have forced researchers to evaluate alternatives for indole alkylations. Alkylations using activated alcohols with acids can provide alkylated indoles, but these additions require vigorous conditions.[10a,15] Transition metal catalysis has been explored for allylation,[16] benzylation[17] and propargylation[18] of indoles with a number of electrophiles, but these catalysts are expensive, often air-sensitive, and may require an additional Lewis acid additive. Transition metals have also been used to introduce sp3-hybridized groups to indoles via Heck type reactions[19] or C-H activation,[20] but these methods are limited in terms of the electrophile. While substantial effort has been expended, selective indole alkylation is still often difficult.[21]
We hypothesized that trichloroacetimidates could provide a useful solution for indole alkylation. Trichloroacetimidates often function as electrophiles in the alkylation of many functional groups including alcohols,[22] carboxylic acids,[23] thiols,[24] anilines,[25] sulfonamides,[26] electron rich alkenes,[27] and aromatic systems.[28] Trichloroacetimidates provide several advantages over alkyl halides. The imidate possesses a basic nitrogen, which may be activated under mild conditions by a catalytic amount of a Lewis acid. In contrast, stoichiometric base or silver salts are often necessary for the alkylation of indoles with alkyl halides.[8b,8c] Imidate displacement is facilitated by rearrangement of the imidate leaving group to trichloroacetamide, providing an additional thermodynamic driving force for alkylation. This rearrangement facilitates Friedel-Crafts alkylations, requiring only a catalytic amount of a Lewis acid with even electron-poor electrophiles.[28a] Trichloroacetimidates are also easily formed from alcohols and trichloroacetonitrile, and the imidates can be generated in situ,[29] providing a method to use inexpensive and readily available alcohols as alkylating agents under mild conditions.
Some alkylation reactions between trichloroacetimidate electrophiles and indoles have been reported.[28d,28f,29–30] Indole itself typically provides C3-alkylation products with trichloroacetimidates.[29b] In cases where C3 is blocked, C2-alkylation usually predominates.[30c] Some aberrant examples have been reported, however, where C2-alkylation could be expected, but instead N-alkylation is observed.[30b] This type of alkylation chemistry may be especially useful in the synthesis of libraries of complex indoles for high throughput screening. Before such a library could be constructed, the efficiency, scope and regiochemistry of the indole alkylation must be further defined. Intrigued by the advantages imidates present over alkyl halides, we initiated an investigation to further explore these imidate-based indole alkylations.
Given our interest in substituted indoles like 5 as inhibitors of the 5’-inositol phosphatase SHIP, we began by evaluating 2-methyl indole 7 as the nucleophile (Table 1). The reaction of 7 with 4-nitrobenzyl trichloroacetimidate 8 was investigated, as the nitro group could be reduced to the corresponding amine to provide an interesting tryptamine analog. TMSOTf was utilized as the Lewis acid as this promoter had proven optimal in other studies on the C3-alkylation of 2,3-disubstituted indoles with trichloroacetimidates.[30f]
Table 1.
Brief optimization of indole alkylation.
![]() | ||||
|---|---|---|---|---|
| Entry | Solvent | Temp. (°C) | Equiv. 8 | Yield |
| 1 | DCE (0.25 M) | 84 | 0.9 | 55 |
| 2 | DCM (0.30 M) | 45 | 0.9 | 48 |
| 3 | DCM (0.30 M) | rt | 0.9 | 51 |
| 4 | DCM (0.10 M) | rt | 0.9 | 41 |
| 5 | DCE (0.25 M) | 84 | 0.5 | 59 |
| 6 | DCM (0.30 M) | rt | 0.5 | 90 |
Heating the reactants in DCM or DCE gave ~50% yield of the desired benzylated indole product 9, but isolation of the product was difficult as the alkylation was complicated by indole polyalkylation products. Attempts were then made to lower the reaction temperature to increase selectivity, however this gave an even more complex mixture of products. The amount of imidate electrophile was then lowered, as the starting benzylic alcohols are inexpensive. Use of excess indole provided a significantly more selective process and facilitated separation and isolation of the product. With conditions in hand to effect the selective C3-alkylation of indoles, the scope of the reaction with regards to trichloroacetimidate electrophile was undertaken (Table 2).
Table 2.
Alkylation of 2-methylindoles with imidates
![]() | ||||
|---|---|---|---|---|
| Entry | Indole | Imidate | Product | Yield |
| 1 | 7 | ![]() |
![]() |
90 |
| 2 | 7 | ![]() |
![]() |
73 |
| 3 | 7 | ![]() |
![]() |
79 |
| 4 | 7 | ![]() |
![]() |
73 |
| 5 | 7 | ![]() |
![]() |
44 |
| 6 | 7 | ![]() |
![]() |
73 |
| 7 | 7 | ![]() |
![]() |
60 |
| 8 | 7 | ![]() |
![]() |
51 |
| 9 10 |
7 10 |
![]() |
![]() |
0a (28) 91 (29) |
| 11 12 |
7 10 |
![]() |
![]() |
0a (31) 28 (32) |
| 13 14 |
7 10 |
![]() |
![]() |
0a (34) 38 (35) |
Product could not be isolated from complex mixture.
Both the m-nitrobenzyl imidate 13 and the o-nitrobenzyl imidate 15 proved to be useful participants, providing the C3-alkylated products in good yield. Other electron poor benzylic imidates also were also successfully employed (entries 4–6). While the isolated yield with the 3,5-dinitrobenzyl imidate 19 was somewhat lower, this was due to difficulties in separating side products, the conversion appeared similar to entries 1–4 by 1H NMR. Secondary imidates were also successfully employed, as shown for indoles 24 and 26. More reactive 4-methoxybenzyl, allyl and phthalimidomethyl trichloroacetimidates (27, 30 and 33) only gave complex mixtures under these reaction conditions due to polyalkylation of the indole. Attempts to limit side product formation utilizing lower temperatures and/or weaker Lewis acids (SnCl2, Sc(OTf)3) were unsuccessful. We speculated that polyalkylation could be overcome by blocking one of the alkylation sites on C5 of the indole with an electron withdrawing group, and therefore 5-nitro-2-methylindole 10 was also evaluated in alkylation reactions with these imidates. Significantly higher yields were obtained in all three cases when indole 10 was used as a substrate, supporting the hypothesis that the parent indole 7 is too reactive and leads to side products when highly reactive imidates are employed as alkylating reagents. The scope of the reaction with different indole nucleophiles was then explored (Table 3).
Table 3.
Alkylation of Different Indoles with 4-Nitrobenzyl trichloroacetimidate
![]() | |||
|---|---|---|---|
| Entry | Indole | Product | Yield |
| 1 | ![]() |
![]() |
72 |
| 2 | ![]() |
![]() |
49 |
| 3 | ![]() |
![]() |
51 |
| 4 | ![]() |
![]() |
45 |
| 5 | ![]() |
![]() |
70 |
| 6 | ![]() |
![]() |
90 |
| 7 | ![]() |
![]() |
83 |
| 8 | ![]() |
![]() |
53 |
| 9 | ![]() |
![]() |
65 |
| 10 | ![]() |
![]() |
82 |
Unsubstituted indole proved an effective substrate under these conditions, providing a 72% yield of product 39. Use of indoles halogenated at the 5-position led to lower a slightly lower conversion of ~50% with either a fluorine, chlorine or bromine substituent (entries 2–4). Chlorination at the 6 position of the indole was better tolerated, providing a 70% yield of indole 47. The influence of a substituent at the C2 position of the indole was also briefly explored, with both a methyl group and a phenyl ring being well tolerated and providing excellent yields of the C3 alkylation product (entries 6 and 7). Some other 2,5-disubstituted indole systems were also evaluated (entries 8–10), and these also provided good yields of the corresponding C3-benzylated indoles.
Analysis of the results in Table 3 indicates a general trend of C2-substituted indoles providing slightly higher yields than with indoles that do not possess a C2 substituent. This may have been due to dialkylation at the C3 and C2 position. To investigate this possibility, indole 39 was reacted with allyl imidate 30, and while a complex mixture of C and N alkylation isomers was observed a 17% yield or the 2-allyl indole product 56 could be isolated by careful chromatography (Scheme 1). Yields were higher when the indole nitrogen was already alkylated, as in the case of protected tryptamine 57 which underwent successful C2 alkylation with both allyl imidate 30 and PMB imidate 27. While the yields for these alkylations were modest, this demonstrates a rapid and modular functionalization of an indole core system which may be useful for the preparation of a diverse range of indoles for biological evaluation.
Scheme 1.
Alkylation of 3-substituted indoles at C2.
Trichloroacetimidates are excellent alkylating agents for indoles. The reaction proceeds best when an excess of the indole nucleophile is utilized to avoid overalkylation products. This method is especially useful for the preparation of different C3-benzyl indoles, which can be rapidly generated and evaluated for their biological activity. Further studies showed that in some cases C2-alkylation is also possible. This work may find applications in medicinal chemistry studies on alkylated indoles, which have been shown to be pharmacologically relevant scaffolds.
Supplementary Material
Highlights.
Indoles may be alkylated by trichloroacetimidates with Lewis acids
Benzylic and allylic imidates are most effective
Electron poor imidates and/or indoles perform best as polyalkylation is lower
Acknowledgments
The National Institute of General Medical Sciences (R15-GM116054) provided partial financial support. Acknowledgement is also made to the Donors of the American Chemical Society Petroleum Research Fund for a New Directions award (54823-ND1).
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Supplementary Material
Supplementary data associated with this article can be found, in the online version, at (insert web address). This material includes detailed experimental procedures and NMR data (1H and 13C spectra).
References and notes
- [1].Gribble GW In Heterocyclic Scaffolds II: Reactions and Applications of Indoles; Springer-Verlag, Heidelberg, 2010; Vol. 26. [Google Scholar]
- [2].(a) Kaushik NK; Kaushik N; Attri P; Kumar N; Kim CH; Verma AK; Choi EH Molecules 18 (2013) 6620–6662; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Chadha N; Silakari O Eur. J. Med. Chem 134 (2017) 159–184; [DOI] [PubMed] [Google Scholar]; (c) Ciulla MG; Kumar K Tetrahedron Lett. 59 (2018) 3223–3233. [Google Scholar]
- [3].Noeren-Mueller A; Reis-Correa I Jr.; Prinz H; Rosenbaum C; Saxena K; Schwalbe HJ; Vestweber D; Cagna G; Schunk S; Schwarz O; Schiewe H; Waldmann H Proc. Natl. Acad. Sci. U. S. A 103 (2006) 10606–10611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Acton JJ; Black RM; Jones AB; Moller DE; Colwell L; Doebber TW; MacNaul KL; Berger J; Wood HB Bioorg. Med. Chem. Lett 15 (2005) 357–362. [DOI] [PubMed] [Google Scholar]
- [5].Miller LM; Keune W-J; Castagna D; Young LC; Duffy EL; Potjewyd F; Salgado-Polo F; Engel Garcia P; Semaan D; Pritchard JM; Perrakis A; Macdonald SJF; Jamieson C; Watson AJ B. J. Med. Chem 60 (2017) 722–748. [DOI] [PubMed] [Google Scholar]
- [6].Zhang C; Qu Y; Niu B Bioorg. Med. Chem 24 (2016) 5781–5786. [DOI] [PubMed] [Google Scholar]
- [7].(a) Viernes DR; Choi LB; Kerr WG; Chisholm JD Med. Res. Rev 34 (2014) 795–824; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM Oncotarget 7 (2016) 73525–73540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].(a) Krell RD; Aharony D; Buckner CK; Keith RA; Kusner EJ; Snyder DW; Bernstein PR; Matassa VG; Yee YK; et, a. Am. Rev. Respir. Dis 141 (1990) 978–981; [DOI] [PubMed] [Google Scholar]; (b) Srinivas K; Srinivasan N; Krishna MR; Reddy CR; Arunagiri M; Lalitha R; Reddy KSR; Reddy BS; Reddy GM; Reddy PP; Kumar MK; Reddy MS Org. Process Res. Dev 8 (2004) 952–954; [Google Scholar]; (c) Goverdhan G; Reddy AR; Sampath A; Srinivas K; Himabindu V; Reddy GM Org. Process Res. Dev 13 (2009) 67–72; [Google Scholar]; (d) Goverdhan G; Reddy AR; Himabindu V; Reddy GM Synth. Commun 43 (2013) 498–504. [Google Scholar]
- [9].(a) Taber DF; Tirunahari PK Tetrahedron 67 (2011) 7195–7210; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Vicente R Org. Biomol. Chem 9 (2011) 6469–6480; [DOI] [PubMed] [Google Scholar]; (c) Gribble GW Perkin 1 (2000) 1045–1075; [Google Scholar]
- [10].(a) Bandini M; Eichholzer A Angew. Chem., Int. Ed 48 (2009) 9608–9644; [DOI] [PubMed] [Google Scholar]; (b) Poulsen TB; Jørgensen KA Chem. Rev 108 (2008) 2903–2915. [DOI] [PubMed] [Google Scholar]; (c) Appleton JE; Dack KN; Green AD; Steele J Tetrahedron Lett. 34 (1993) 1529–1532. [Google Scholar]
- [11].Garcia JM; Oiarbide M; Palomo C Michael addition: chelating α,β-unsaturated compounds In Catalytic Asymmetric Friedel-Crafts Alkylations; Wiley-VCH, Weinheim, 2009. pp 17–99. [Google Scholar]
- [12].(a) Pelkey ET Top. Heterocycl. Chem 26 (2010) 141–191; [Google Scholar]; (b) Li JJ; Gribble GW Top. Heterocycl. Chem 26 (2010) 193–234; [Google Scholar]; (c) Joucla L; Djakovitch L Adv. Synth. Catal 351 (2009) 673–714; [Google Scholar]; (d) Toure BB; Lane BS; Sames D Org. Lett 8 (2006) 1979–1982; [DOI] [PubMed] [Google Scholar]; (e) Dwight TA; Rue NR; Charyk D; Josselyn R; DeBoef B Org. Lett 9 (2007) 3137–3139; [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Widenhoefer RA Unactivated alkenes In Catalytic Asymmetric Friedel-Crafts Alkylations; Wiley-VCH, Weinheim, 2009. pp 203–222. [Google Scholar]
- [13].Bandini M; Cozzi PG Nucleophilic substitution on Csp3 carbon atoms In Catalytic Asymmetric Friedel-Crafts Alkylations; Wiley-VCH, Weinheim, 2009. pp 167–202. [Google Scholar]
- [14].(a) Zhu X; Ganesan AJ Org. Chem 67 (2002) 2705–2708; [DOI] [PubMed] [Google Scholar]; (b) Westermaier M; Mayr H Org. Lett 8 (2006) 4791–4794; [DOI] [PubMed] [Google Scholar]; (c) Bandini M; Melloni A; Umani-Ronchi A Org. Lett 6 (2004) 3199–3202. [DOI] [PubMed] [Google Scholar]
- [15].(a) Vicennati P; Cozzi PG Eur. J. Org. Chem (2007) 2248–2253; [Google Scholar]; (b) Chung JYL; Mancheno D; Dormer PG; Variankaval N; Ball RG; Tsou NN Org. Lett 10 (2008) 3037–3040; [DOI] [PubMed] [Google Scholar]; (c) Han X; Wu J Angew. Chem., Int. Ed 52 (2013) 4637–4640; [DOI] [PubMed] [Google Scholar]; (d) Bandini M; Tragni M Org. Biomol. Chem 7 (2009) 1501–1507. [DOI] [PubMed] [Google Scholar]
- [16].(a) Zaitsev AB; Gruber S; Pregosin PS Chem. Commun (2007) 4692–4693; [DOI] [PubMed] [Google Scholar]; (b) Usui I; Schmidt S; Keller M; Breit B Org. Lett 10 (2008) 1207–1210; [DOI] [PubMed] [Google Scholar]; (c) Liu W-B; He H; Dai L-X; You S-L Org. Lett 10 (2008) 1815–1818; [DOI] [PubMed] [Google Scholar]; (d) Xu Q-L; Dai L-X; You S-L Chem. Sci 4 (2013) 97–102; [Google Scholar]; (e) Kimura M; Futamata M; Mukai R; Tamaru YJ Am. Chem. Soc 127 (2005) 4592–4593; [DOI] [PubMed] [Google Scholar]; (f) Billups WE; Erkes RS; Reed LE Synth. Commun 10 (1980) 147–154; [Google Scholar]
- [17].(a) Zhu Y; Rawal VH J. Am. Chem. Soc 134 (2012) 111–114; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Montgomery TD; Zhu Y; Kagawa N; Rawal VH Org. Lett 15 (2013) 1140–1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].(a) Matsuzawa H; Miyake Y; Nishibayashi Y Angew. Chem., Int. Ed 46 (2007) 6488–6491; [DOI] [PubMed] [Google Scholar]; (b) Matsuzawa H; Kanao K; Miyake Y; Nishibayashi Y Org. Lett 9 (2007) 5561–5564; [DOI] [PubMed] [Google Scholar]; (c) Kanao K; Matsuzawa H; Miyake Y; Nishibayashi Y Synthesis (2008) 3869–3873. [Google Scholar]
- [19].(a) Krause N; Winter C Chem. Rev 111 (2011) 1994–2009; [DOI] [PubMed] [Google Scholar]; (b) Zeldin RM; Toste FD Chem. Sci 2 (2011) 1706–1709; [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Barluenga J; Piedrafita M; Ballesteros A; Suarez-Sobrino AL; Gonzalez JM Chem. Eur. J 16 (2010) 11827–11831. [DOI] [PubMed] [Google Scholar]
- [20].Luzung M,R; Lewis C,A; Baran P,S Angew. Chem. Int. Ed. Engl 48 (2009) 7025–7029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Lindel T; Marsch N; Adla SK Top. Curr. Chem 309 (2012) 67–130. [DOI] [PubMed] [Google Scholar]
- [22].(a) Iversen T; Bundle DRJ Chem. Soc., Chem. Commun (1981) 1240–1241; [Google Scholar]; (b) Nakajima N; Horita K; Abe R; Yonemitsu O Tetrahedron Lett. 29 (1988) 4139–4142; [Google Scholar]; (c) Schmidt RR; Michel J Angew. Chem. Int. Ed. Engl 19 (1980) 731–732; [Google Scholar]; (d) Howard KT; Duffy BC; Linaburg MR; Chisholm JD Org. Biomol. Chem 14 (2016) 1623–1628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].(a) Armstrong A; Brackenridge I; Jackson RFW; Kirk JM Tetrahedron Lett. 29 (1988) 2483–2486; [Google Scholar]; (b) Thierry J; Yue C; Potier P Tetrahedron Lett. 39 (1998) 1557–1560; [Google Scholar]; (c) Shah JP; Russo CM; Howard KT; Chisholm JD Tetrahedron Lett. 55 (2014) 1740–1742; [Google Scholar]; (d) Adhikari AA; Shah JP; Howard KT; Russo CM; Wallach DR; Linaburg MR; Chisholm JD Synlett (2014) 283–287. [Google Scholar]
- [24].Duffy BC; Howard KT; Chisholm JD Tetrahedron Lett. 56 (2015) 3301–3305. [Google Scholar]
- [25].(a) Arnold JS; Nguyen HM Synthesis 45 (2013) 2101–2108; [Google Scholar]; (b) Arnold JS; Stone RF; Nguyen HM Org. Lett 12 (2010) 4580–4583; [DOI] [PubMed] [Google Scholar]; (c) Wallach DR; Stege PC; Shah JP; Chisholm JD J. Org. Chem 80 (2015) 1993–2000. [DOI] [PubMed] [Google Scholar]
- [26].Wallach DR; Chisholm JD J. Org. Chem 81 (2016) 8035–8042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].(a) Hoffmann MG; Schmidt RR Liebigs Ann. Chem (1985) 2403–2419; [Google Scholar]; (b) Ali IAI; El Ashry ESH; Schmidt RR Tetrahedron 60 (2004) 4773–4780. [Google Scholar]
- [28].(a) Zhang J; Schmidt RR Synlett (2006) 1729–1733; [Google Scholar]; (b) Schmidt RR; Hoffmann M Tetrahedron Lett. 23 (1982) 409–412; [Google Scholar]; (c) Mahling JA; Schmidt RR Synthesis (1993) 325–328; [Google Scholar]; (d) Li C; Wang JJ Org. Chem 72 (2007) 7431–7434; [DOI] [PubMed] [Google Scholar]; (e) Adhikari AA; Chisholm JD Org. Lett 18 (2016) 4100–4103; [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Schmidt RR; Effenberger G Liebigs Ann. Chem (1987) 825–831. [Google Scholar]
- [29].(a) Devineau A; Pousse G; Taillier C; Blanchet J; Rouden J; Dalla V Adv. Synth. Catal 352 (2010) 2881–2886; [Google Scholar]; (b) Piemontesi C; Wang Q; Zhu J Org. Biomol. Chem 11 (2013) 1533–1536. [DOI] [PubMed] [Google Scholar]
- [30].(a) El-Desoky ESI; Abdel Rahman HAR; Schmidt RR Liebigs Ann. Chem (1990) 877–881; [Google Scholar]; (b) Schnabel M; Römpp B; Ruckdeschel D; Unverzagt C Tetrahedron Lett. 45 (2004) 295–297; [Google Scholar]; (c) Tokuyama H; Okano K; Fujiwara H; Noji T; Fukuyama T Chem. Asian J 6 (2011) 560–572; [DOI] [PubMed] [Google Scholar]; (d) Wiebe C; Schlemmer C; Weck S; Opatz T Chem. Commun 47 (2011) 9212–9214; [DOI] [PubMed] [Google Scholar]; (e) Wiebe C; Fuste de la Sotilla S; Opatz T Synthesis 44 (2012) 1385–1397; [Google Scholar]; (f) Adhikari AA; Radal L; Chisholm JD Synlett 28 (2017) 2335–2339. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.















































